Developing inobrodib (CCS1477), first-in-class p300/CBP inhibitor to treat specific cancers.
Other organizations in the same industry
A collaboration of scientists, clinicians, patients and advocates to rapidly understand and treat Lo...
Your Bridge from ATMPs Concept to Commercialization
Gediflora is a global player when it comes to the breeding and propagation of ball-shaped chrysanthe...
This company is also known as